Blood Transfusion Diagnostics Market Research Report - Forecast to 2027

Blood Transfusion Diagnostics Market Information, by product (Red Blood Cells, Platelets, Plasma, Albumin, Immunoglobulin Preparations, others) by Technology (Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test, others) by end user (Hospitals, Clinics, Blood banks, Laboratories) - Forecast till 2027

ID: MRFR/LS/0620-HCR | August 2022 | Region: Global | 200 Pages         

Table of Contents

1. Report Prologue

2. Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

3. Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Threats

4.5 Macroeconomic Indicators

5. Market Factor Analysis

5.1 Value Chain Analysis

5.2 Porters Five Forces

5.3 Demand & supply: gap analysis

5.4 Pricing Analysis

5.5 Investment Opportunity Analysis

5.6 Merger and Acquisition Landscape

5.7 Up-Coming trends in Blood Transfusion Diagnostics market

5.7.1 Market trends

5.7.2 Technological trends

6. Global Blood Transfusion Diagnostics market by product

6.1 Red Blood Cells

6.2 Platelets

6.3 Plasma

6.4 Albumin

6.5 Immunoglobulin Preparations

7. Global Blood Transfusion Diagnostics market by technology

7.1 Western Blot

7.2 ELISA

7.2.1 Chemiluminescence immunoassay

7.2.2 Fluorescence immunoassays

7.3.3 Colorimetric immunoassay

7.3 Nucleic Acid Amplification

7.3.1 Thermomechanical analysis (TMA)

7.3.2 Real-time PCR

7.4 Fluorescence assay

7.5 Rapid Test

8. Global Blood Transfusion Diagnostics market by end user

8.1 Hospitals

8.2 Clinics

8.3 Blood banks

8.4 Laboratories

9. Global Blood Transfusion Diagnostics market by region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 UK

9.3.1.3 France

9.3.1.4 Italy

9.3.1.5 Spain

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Republic of Korea

9.4.5 Australia

9.4.6 Rest of Asia-Pacific

9.5 Middle East and Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Qatar

9.5.5 Kuwait

9.5.6 Rest of Middle East and Africa

10 Competitive Landscape

11 Company Profile

11.1 Grifols

11.1.1 Overview

11.1.2 Product/Business Segment Overview

11.1.3 Financial Updates

11.1.4 Key Developments

11.2 Thermo Fisher Scientific, Inc.

11.2.1 Overview

11.2.2 Product/Business Segment Overview

11.2.3 Financial Updates

11.2.4 Key Developments

11.3 Roche Diagnostics

11.3.1 Overview

11.3.2 Product/Business Segment Overview

11.3.3 Financial Updates

11.3.4 Key Developments

11.4 Biomérieux

11.4.1 Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Updates

11.4.4 Key Development

11.5 Bio-Rad Laboratories, Inc.

11.5.1 Overview

11.5.2 Product/Business Segment Overview

11.5.3 Financial Updates

11.5.4 Key Developments

11.6 Immucor

11.6.1 Overview

11.6.2 Product/Business Segment Overview

11.6.3 Financial Updates

11.6.4 Key Developments

11.7 Siemens Healthineers

11.7.1 Overview

11.7.2 Product/Business Segment Overview

11.7.3 Financial Updates

11.7.4 Key Developments

11.8 Becton, Dickinson and Company

11.8.1 Overview

11.8.2 Product/Business Segment Overview

11.8.3 Financial Updates

11.8.4 Key Developments

11.9 Others

12 Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Blood Transfusion Diagnostics Industry

13 Appendix


LIST OF TABLES

Table 1 Blood Transfusion Diagnostics Industry Synopsis, 2020-2027

Table 2 Global Blood Transfusion Diagnostics Market Estimates & Forecast, 2020-2027, (USD Million)

Table 3 Global Blood Transfusion Diagnostics Market, by Region, 2020-2027, (USD Million)

Table 4 Global Blood Transfusion Diagnostics Market, by Product, 2020-2027, (USD Million)

Table 5 Global Blood Transfusion Diagnostics Market, by Technology, 2020-2027, (USD Million)

Table 6 Global Blood Transfusion Diagnostics Market, by End-User, 2020-2027, (USD Million)

Table 7 Americas Blood Transfusion Diagnostics Market, by Product, 2020-2027, (USD Million)

Table 8 Americas Blood Transfusion Diagnostics Market, by Technology, 2020-2027, (USD Million)

Table 9 Americas Blood Transfusion Diagnostics Market, by End-User, 2020-2027, (USD Million)

Table 10 North America Blood Transfusion Diagnostics Market, by Product, 2020-2027, (USD Million)

Table 11 North America Blood Transfusion Diagnostics Market, by Technology, 2020-2027, (USD Million)

Table 12 North America Blood Transfusion Diagnostics Market, by End-User, 2020-2027, (USD Million)

Table 13 South America Blood Transfusion Diagnostics Market, by Product, 2020-2027, (USD Million)

Table 14 South America Blood Transfusion Diagnostics Market, by Technology, 2020-2027, (USD Million)

Table 15 South America Blood Transfusion Diagnostics Market, by End-User, 2020-2027, (USD Million)

Table 16 Europe Blood Transfusion Diagnostics Market, by Product, 2020-2027, (USD Million)

Table 17 Europe Blood Transfusion Diagnostics Market, by Technology, 2020-2027, (USD Million)

Table 18 Europe Blood Transfusion Diagnostics Market, by End-User, 2020-2027, (USD Million)

Table 19 Western Europe Blood Transfusion Diagnostics Market by Product, 2020-2027, (USD Million)

Table 20 Western Europe Blood Transfusion Diagnostics Market, by Technology, 2020-2027, (USD Million)

Table 21 Western Europe Blood Transfusion Diagnostics Market, by End-User, 2020-2027, (USD Million)

Table 22 Eastern Europe Blood Transfusion Diagnostics Market, by Product, 2020-2027, (USD Million)

Table 23 Eastern Europe Blood Transfusion Diagnostics Market, by Technology, 2020-2027, (USD Million)

Table 24 Eastern Europe Blood Transfusion Diagnostics Market, by End-User, 2020-2027, (USD Million)

Table 25 Asia Pacific Blood Transfusion Diagnostics Market, by Product, 2020-2027, (USD Million)

Table 26 Asia Pacific Blood Transfusion Diagnostics Market, by Technology, 2020-2027, (USD Million)

Table 27 Asia Pacific Blood Transfusion Diagnostics Market, by End-User, 2020-2027, (USD Million)

Table 28 Middle East & Africa Blood Transfusion Diagnostics Market, by Product, 2020-2027, (USD Million)

Table 29 Middle East & Africa Blood Transfusion Diagnostics Market, by Technology, 2020-2027, (USD Million)

Table 30 Middle East & Africa Blood Transfusion Diagnostics Market, by End-User, 2020-2027, (USD Million) 

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Blood Transfusion Diagnostics Market

Figure 3 Segmentation Market Dynamics for Blood Transfusion Diagnostics Market

Figure 4 Global Blood Transfusion Diagnostics Market Share, by Product 2020

Figure 5 Global Blood Transfusion Diagnostics Market Share, by Technology 2020

Figure 6 Global Blood Transfusion Diagnostics Market Share, by End Users, 2020

Figure 7 Global Blood Transfusion Diagnostics Market Share, by Region, 2020

Figure 8 Americas Blood Transfusion Diagnostics Market Share, by Country, 2020

Figure 9 Europe Blood Transfusion Diagnostics Market Share, by Country, 2020

Figure 10 Asia Pacific Blood Transfusion Diagnostics Market Share, by Country, 2020

Figure 11 Middle East & Africa Blood Transfusion Diagnostics Market Share, by Country, 2020

Figure 12 Global Blood Transfusion Diagnostics Market: Company Share Analysis, 2020 (%)

Blood Transfusion Diagnostics Market

Blood Transfusion Diagnostics Market Size is expected to reach USD 2.45 billion in 2028 from USD 1.50 billion in 2019 with a CAGR of approximately 8.2% during the forecast period 2021-2028.

Segmentation

By Product Red Blood Cells Platelets Plasma Albumin Immunoglobulin Preparations Others
By Technology Western Blot Elisa Nucleic Acid Amplification Fluorescence Assay Rapid Test Others
By End-User Hospitals Clinics Blood Banks Laboratories

Key Players

  • Grifols (Spain)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Roche Diagnostics (Switzerland)
  • bioMérieux (France)
  • Bio-Rad Laboratories Inc. (U.S.)
  • Immucor (U.S)
  • Siemens Healthineers (Germany)
  • Ortho Clinical Diagnostics Inc. (U.S.)
  • Becton
  • Dickinson and Company (U.S.)
  • Novartis AG (Switzerland)
  • Beckman Coulter Inc. (U.S.)
  • Ortho Clinical Diagnostics (U.S)
  • Diagast (France)
  • Abbott Diagnostics (U.S)
  • BAG healthcare (Germany)
  • DiaSorin (Italy)
  • Fujirebio (Belgium)
  • Grifols (Spain)
  • Quidel (U.S)
  • Hologic/Gen-Probe (U.S)
  • Biokit (Spain).

Drivers

  • Increasing volume of blood transfusions is likely to be a key driver for the Blood Transfusion Diagnostics Market.
Speak to Analyst Request a Free Sample

Blood Transfusion Diagnostics Market Overview
 
Blood Transfusion Diagnostics Market Size is expected to reach USD 2.45 billion in 2023 from USD 1.50 billion in 2016 with a CAGR of approximately 8.2% during the forecast period. Blood transfusion diagnostics is the intravenous transfer of blood or blood products. Blood transfusions can be used to replace blood components that have been lost. The most common blood components transfused include red blood cells, white blood cells, platelets, clotting factors, and plasma. During an emergency or a serious case of massive blood loss, these blood components are crucial to laboratories and hospitals. When hemoglobin levels fall below 100g/L, RBC transfusion is required. Before being transfused, blood from a donor must be checked for a variety of infectious diseases. Blood transfusion demand is being driven by the rising prevalence of chronic and infectious diseases such as severe anemia, cancer, hemophilia, kidney disease, liver disease, severe infection, sickle cell disease, and thrombocytopenia, as well as the introduction of technologically advanced products.
 
As a result, blood transfusion diagnostics play a vital role in preventing infection in both the recipient and the healthcare workers. The expansion of this market is fueled by rising infectious disease prevalence, an increase in the number of blood transfusion procedures, the need for screened blood products, and increased campaigning or awareness campaigns. The demand for blood and blood products outnumbers the supply, adding to the Blood Transfusion Diagnostics market's expansion.

Study objectives: Main objective of this research is to provide information about Blood Transfusion Diagnostics market, product, technology and end users.



  • To provide detailed analysis of the market structure along with forecast for the next seven years of the various segments and sub-segments of the Blood Transfusion Diagnostics market.

  • To provide insights about factors affecting the market growth.

  • To analyze the Blood Transfusion Diagnostics market based on various factors- Price Analysis, Supply Chain Analysis, Porters’ Five Force Analysis etc.

  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies - Americas, Europe, Asia Pacific and Middle East & Africa and their countries.

  • To provide country level analysis of the market with respect to the current market size and future prospective.

  • To provide country level analysis of the market for segments by product, by technology, by end and its sub-segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the Blood Transfusion Diagnostics Market.

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Blood Transfusion Diagnostics market.


Recent Development

Ortho Clinical Diagnostics introduced the ORTHO VISION Swift and ORTHO VISION Max Swift analyzers in April 2021. These analyzers provide laboratory networks with more processing power and enhanced data security.
 
Hemanext, a blood storage technology company, said in September 2021 that it would raise USD 15 million in a new series A fundraising round and USD 100 million from private equity. Its goal is to spread the Hemanext One System's processes all over the world. The technology has a CE designation, which means it can be sold throughout Europe.

Intended Audience



  • Medical device manufactures

  • Medical devices suppliers

  • Contract Research Organizations (CROs)

  • Research and Development (R&D) Companies

  • Academic Medical Institutes and Universities


Figure 1: Blood Transfusion Diagnostics market, by technology, 2016:


 Blood Transfusion Diagnostics market


Source: Press Release, Company presentation, annual reports


Segmentation:


Blood Transfusion Diagnostics market has been segmented on the basis of blood product including Red Blood Cells, Platelets, Plasma, Albumin, Immunoglobulin Preparations and other products. On the basis of technology, the market is segmented into Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test and other technologies. ELISA is further segmented into chemiluminescence immunoassay (CLIA), fluorescence immunoassays (FIA), and colorimetric immunoassay (CI). Nucleic Acid Amplification is segmented into Thermomechanical analysis (TMA) and real-time PCR. End users are hospitals, clinics, blood banks, laboratories.


Regional Analysis:


Globally, Blood Transfusion Diagnostics market consists of four regions Americas, Europe, Asia Pacific and Middle East and Africa. America is the largest market whose growth is attributed to an increase in the use of nucleic acid amplification test and large number of awareness programs conducted by the government bodies and non-government organizations. Europe is the second largest market. Asia Pacific is showing positive growth this market. The market shows steady growth in Middle East & Africa.


Figure 2: Market Synopsis Blood Transfusion Diagnostics Synopsis


Sources: Press Release, presentation, company website, annual reports, government records, journals expert interview.


Key Players


Grifols (Spain), Thermo Fisher Scientific, Inc. (U.S.), Roche Diagnostics (Switzerland), bioMérieux (France), Bio-Rad Laboratories, Inc. (U.S.), Immucor (U.S),  Siemens Healthineers (Germany), Ortho Clinical Diagnostics, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Novartis AG (Switzerland), Beckman Coulter, Inc. (U.S.), Ortho Clinical Diagnostics (U.S), Beckman Coulter (U.S), Diagast (France), Abbott Diagnostics (U.S), BAG healthcare (Germany),  DiaSorin (Italy), Fujirebio (Belgium), Grifols (Spain), Quidel (U.S), Hologic/Gen-Probe (U.S), Biokit (Spain).


The report for Blood Transfusion Diagnostics market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions



Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

Global Blood Transfusion Diagnostics Market is expected to be valued at USD 2.45 billion in 2023, rising from USD 1.5 billion in 2016.

Blood Transfusion Diagnostics Market is expected to exhibit a strong 8.2% CAGR over the forecast period from 2017 to 2023.

Increasing volume of blood transfusions is likely to be a key driver for the Blood Transfusion Diagnostics Market.

Americas are the largest Blood Transfusion Diagnostics Market.

Leading players in the Blood Transfusion Diagnostics Market include Roche Diagnostics, Thermo Fisher, and Grifols, among others.